Advertisement


Jimmie C. Holland, MD, and Tammy A. Schuler, PhD, on Talking With Patients About Their Distress: A Demonstration

2015 IPOS APOS World Congress of Psycho-Oncology

Advertisement

Jimmie C. Holland, MD, of Memorial Sloan Kettering Cancer Center, and Tammy A. Schuler, PhD, of the Association for Behavioral and Cognitive Therapies, demonstrate a dialogue between a clinician and a recently diagnosed cancer patient whose distress was discovered with the use of the Distress Thermometer.



Related Videos

Supportive Care

Mark Lazenby, PhD, APRN, FAPOS, on Distress Screening in the Community Setting

Mark Lazenby, PhD, APRN, FAPOS, of the Yale School of Nursing, discusses the APOS–ACCC project to screen for psychosocial distress in community cancer centers. These model programs improve patient care and the patient experience.

Supportive Care

Allison J. Applebaum, PhD, and William S. Breitbart, MD, on Workshops in Meaning-Centered Psychotherapy

Allison J. Applebaum, PhD, and William S. Breitbart, MD, of Memorial Sloan Kettering Cancer Center, discuss a meaning-centered psychotherapy workshop they conducted for an international group of clinicians.

Supportive Care

Allison J. Applebaum, PhD, and William S. Breitbart, MD, on Meaning-Centered Psychotherapy for Cancer Patients

Allison J. Applebaum, PhD, and William S. Breitbart, MD, of Memorial Sloan Kettering Cancer Center, discuss a powerful treatment approach that is grounded in a moving personal story.

Survivorship
Supportive Care

Andrea F. Patenaude, PhD, on Standards for Psychosocial Care of Children With Cancer

Andrea F. Patenaude, PhD, of Dana-Farber Cancer Institute, discusses the challenges to implementing standards for pediatric and adolescent psycho-oncology and looks ahead at next steps in the field.

Survivorship
Supportive Care
Prostate Cancer

Christopher J. Recklitis, PhD, MPH, on The Risk of Suicide After a Cancer Diagnosis

Christopher J. Recklitis, PhD, MPH, of the Dana-Farber Cancer Institute, discusses what is known about suicide after cancer, the risks faced by prostate cancer patients within the first year after diagnosis, and challenges across the treatment trajectory

Advertisement

Advertisement




Advertisement